thioctic acid has been researched along with alpha-synuclein in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, N; Jia, H; Li, X; Liu, J; Luo, C; Shen, W; Wang, X; Yan, B; Zhang, H | 1 |
| Phillipson, OT | 1 |
| Jiao, L; Tai, S; Zhai, S; Zhang, C; Zhang, X | 1 |
1 review(s) available for thioctic acid and alpha-synuclein
| Article | Year |
|---|---|
Management of the aging risk factor for Parkinson's disease.
Topics: Acetylcarnitine; Adenosine Triphosphate; Aging; alpha-Synuclein; Antioxidant Response Elements; Carbohydrate Metabolism; Electron Transport; Energy Metabolism; Fatty Acids; Glial Cell Line-Derived Neurotrophic Factor; Humans; Inflammation; Melatonin; Mitochondria; Nitric Oxide; Oxidative Stress; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Proteostasis Deficiencies; Risk Factors; Thioctic Acid; Transcription Factors; Ubiquinone | 2014 |
2 other study(ies) available for thioctic acid and alpha-synuclein
| Article | Year |
|---|---|
Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease.
Topics: Acetylcarnitine; alpha-Synuclein; Antioxidants; Drug Synergism; Humans; Mitochondria; Oxidation-Reduction; Oxidative Stress; Parkinson Disease; Rotenone; Thioctic Acid; Ubiquitin; Uncoupling Agents | 2010 |
[Alpha-lipoic acid inhibits the expression of α-synuclein in PC12 cells induced by 6-hydroxydopamine and its mechanism].
Topics: alpha-Synuclein; Animals; Oxidopamine; PC12 Cells; Rats; Thioctic Acid | 2018 |